MRNA · ISSUER CIK 1682852
Moderna, Inc.
Between Jul 31, 2026 and Oct 28, 2026, 4 Moderna, Inc. insiders reported $0.00 of open-market purchases and $62.6M of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 5 of 5 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$62.6MInsider selling
−$62.6MNet open-market
Oct 16, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 202616:09 | Oct 15, 2026from Oct 14, 2026 | MRNA | President | S · Sell10b5-1 | $217.10 | −78,369 | 1,636,565 | -5% | −$17.0M | ||
| Oct 16, 202616:09 | Oct 15, 2026from Oct 14, 2026 | MRNA | President | M · Exercise10b5-1 | $12.21 | +152,905 | 1,675,710 | +10% | $1.9M | ||
| Oct 7, 202616:04 | Oct 5, 2026 | MRNA | Chief Financial Officer | M · Exercise | — | +1,454 | 60,829 | +2% | — | ||
| Oct 7, 202616:04 | Oct 5, 2026 | MRNA | Chief Financial Officer | F · Tax | $190.01 | −704 | 60,125 | -1% | $134K | ||
| Sep 16, 202616:48 | Sep 15, 2026from Sep 14, 2026 | MRNA | President | S · Sell10b5-1 | $145.10 | −80,575 | 1,562,029 | -5% | −$11.7M | ||
| Sep 16, 202616:48 | Sep 15, 2026from Sep 14, 2026 | MRNA | President | M · Exercise10b5-1 | $12.21 | +152,905 | 1,602,310 | +11% | $1.9M | ||
| Sep 14, 202616:25 | Sep 10, 2026 | MRNA | Chief Financial Officer | S · Sell10b5-1 | $134.49 | −34,836 | 59,375 | -37% | −$4.7M | ||
| Sep 14, 202616:25 | Sep 10, 2026 | MRNA | Chief Financial Officer | M · Exercise10b5-1 | $30.96 | +19,836 | 94,211 | +27% | $614K | ||
| Sep 8, 202617:02 | Sep 4, 2026 | MRNA | Chief Financial Officer | M · Exercise | — | +11,797 | 80,079 | +17% | — | ||
| Sep 8, 202617:02 | Sep 4, 2026 | MRNA | Chief Financial Officer | F · Tax | $148.87 | −5,704 | 74,375 | -7% | $849K | ||
| Sep 8, 202616:57 | Sep 4, 2026 | MRNA | Chief Legal Officer | M · Exercise | — | +11,797 | 87,044 | +16% | — | ||
| Sep 8, 202616:57 | Sep 4, 2026 | MRNA | Chief Legal Officer | F · Tax | $148.87 | −5,704 | 81,340 | -7% | $849K | ||
| Sep 3, 202616:56 | Sep 1, 2026 | MRNA | Chief Legal Officer | S · Sell10b5-1 | $139.95 | −3,471 | 74,129 | -4% | −$486K | ||
| Sep 3, 202616:56 | Sep 1, 2026 | MRNA | Chief Legal Officer | M · Exercise10b5-1 | $19.06 | +5,637 | 76,295 | +8% | $107K | ||
| Sep 3, 202616:56 | Sep 1, 2026 | MRNA | Chief Legal Officer | F · Tax10b5-1 | $140.34 | −1,048 | 75,247 | -1% | $147K | ||
| Sep 3, 202616:52 | Sep 1, 2026 | MRNA | Chief Financial Officer | M · Exercise | — | +2,475 | 69,479 | +4% | — | ||
| Sep 3, 202616:52 | Sep 1, 2026 | MRNA | Chief Financial Officer | F · Tax | $140.34 | −1,197 | 68,282 | -2% | $168K | ||
| Sep 3, 202616:50 | Sep 1, 2026 | MRNA | President | M · Exercise | — | +9,283 | 1,494,188 | +1% | — | ||
| Sep 3, 202616:50 | Sep 1, 2026 | MRNA | President | F · Tax | $140.34 | −4,489 | 1,489,699 | -0% | $630K | ||
| Aug 31, 202616:51 | Aug 28, 2026from Aug 27, 2026 | MRNA | President | M · Exercise | — | +2,048 | 1,485,201 | +0% | — | ||
| Aug 31, 202616:51 | Aug 28, 2026from Aug 27, 2026 | MRNA | President | F · Tax | $147.60 | −991 | 1,484,905 | -0% | $146K | ||
| Aug 31, 202616:37 | Aug 28, 2026from Aug 27, 2026 | MRNA | Chief Legal Officer | M · Exercise | — | +1,103 | 74,289 | +2% | — | ||
| Aug 31, 202616:37 | Aug 28, 2026from Aug 27, 2026 | MRNA | Chief Legal Officer | F · Tax | $147.60 | −535 | 74,129 | -1% | $79K | ||
| Aug 31, 202616:34 | Aug 28, 2026from Aug 27, 2026 | MRNA | Chief Financial Officer | M · Exercise | — | +1,103 | 67,164 | +2% | — | ||
| Aug 31, 202616:34 | Aug 28, 2026from Aug 27, 2026 | MRNA | Chief Financial Officer | F · Tax | $147.60 | −535 | 67,004 | -1% | $79K | ||
| Aug 7, 202616:11 | Aug 5, 2026 | MRNA | Chief Executive Officer, Director | S · Sell10b5-1 | $57.52 | −499,246 | 6,187,791 | -7% | −$28.7M | ||
| Aug 7, 202616:11 | Aug 6, 2026from Aug 5, 2026 | MRNA | Chief Executive Officer, Director | M · Exercise10b5-1 | $19.15 | +751,715 | 6,440,260 | +13% | $14.4M |